Clinical trial
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic…
NCT00435591 · Cumberland Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00435591 |
|---|---|
| Title | A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia |
| Official title | A Phase 4, Randomized, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia |
| Lead sponsor | Cumberland Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hyponatremia, Euvolemia, Hypervolemia |
| Intervention type | Drug |
| Interventions | Conivaptan, placebo |
| Enrollment | 121 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 15, 2007 |
| Last update posted | May 15, 2014 |
| Countries | India, Israel, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: